Securities Fraud

<p>A federal court in Indiana <a href="http://www.courthousenews.com/wp-content/uploads/2020/05/securitiesfraudsettlement.pdf"><strong>approved</strong></a> a $50 million settlement in a class action securities fraud case brought by investors against medical device company Zimmer Biomet Holdings. The investors claimed the company failed to disclose supply chain problems that led to a decrease in order fulfillment rates.</p>

SOUTH BEND, Ind. — A federal court in Indiana approved a $50 million settlement in a class action securities fraud case brought by investors against medical device company Zimmer Biomet Holdings. The investors claimed the company failed to disclose supply-chain problems that led to a decrease in order fulfillment rates.

Categories / Business, Securities

Subscribe to our free newsletters

Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.